
By
Julie Thibeau
The new buzz around the market seems to be "Theanine". So what exactly is
L-Theanine? L-Theanine is a unique amino acid commonly found in Green Tea.
First introduced centuries ago in Southeast Asia, tea has become the most
widely consumed beverage worldwide aside from water and it is now cultivated in
more than 30 different countries.
Tea leaves are a natural source of L-Theanine, however, only 1 2 % of
the dry weight of tea leaves consists of L-Theanine. It is a very time
consuming and expensive process to extract L-Theanine from tea leaves, and
impossible to yield a 100% purity naturally.
One of the pioneers of Green Tea Extract, Taiyo Kagaku Co., Ltd., Japan, has
developed a patented enzymatic technology to synthesize 100% pure L-Theanine
(Suntheanine®), sold through NutriScience Innovations, LLC.
Suntheanine® is structurally identical to the L-Theanine
compound naturally found in tea.
L-Theanine was first discovered in tea leaves in 1950 and was given food
additive approval by the Japanese Ministry of Health and Welfare since
1964.
Suntheanine® has been extensively researched and documented
with over 45 different studies currently available. Most areas of research
include cancer adjuvant therapy, reducing stress and anxiety, promoting
relaxation, improving learning and concentration, etc.
It should be noted that all research was conducted using
Suntheanine® (100% pure L-Theanine) and not L-Theanine from
Green Tea Extract.
HOW SUNTHEANINE® WORKS:
Suntheanine® is absorbed through the brush-border membrane in
the large intestine and transported directly to the brain where it stimulates
the generation of Alpha brain waves.
The brain transmits four different categories of brain waves which are
determined by frequency: Gamma (), Theta (), Alpha (a) and Beta (). Gamma waves
are present during sound sleep and Theta waves indicated dozing or sleeping.
While Beta waves are present during an awake, excited state, Alpha waves
signify an awake, relaxed state.
Because Suntheanine® promotes Alpha wave generation in the
brain, an awake, alert and relaxed physical and mental condition is achieved.
Dosage of Suntheanine® is effective at 50 200 mg and its
effects are exhibited within 30 40 minutes of consumption.
RESEARCH:
Suntheanine® has been shown to work antagonistically against
the negative side effects of caffeine and ephedrine. After injecting mice with
Suntheanine® intraperitoneally or subcutaneiously, Kimura and
Murata reported that Suntheanine® effectively decreased
convulsions induced by high doses of caffeine and the spontaneous
motor activity produced by lower caffeine doses. Suntheanine®
has also been found effective in reducing the hypertension and disturbance of
sleep often associated with the use of caffeine.
Suntheanine® also diminishes the normal symptoms of
Premenstrual Syndrome. In a study conducted in cooperation with Taiyo Kagaku
Co., Ltd., University of Shizuoka and The Family Planning Institute of Japan,
it was found that 200 mg Suntheanine® per day significantly
reduced physical, mental and social symptoms of PMS such as insomnia, muscle
stiffness, cramps, depression, anxiety, irritability, etc.
It has also been found that Suntheanine® enhances the
anti-tumor activity of such anticancer drugs as doxorubicin, idarubicin and
adriamycin.
Mice with ovarian sarcoma injected with adriamycin alone did not exhibit
tumor weight reduction. When the mice were injected with a combination of
adriamycin and Suntheanine®, tumor weight was reduced by 62%. It
was determined that Suntheanine® increased adriamycin
concentration in the tumors, but decreased adriamycin concentration in healthy
tissues, exhibiting its effectiveness in clinical chemotherapy.
PATENTS & STRUCTURE/FUNCTION CLAIMS:
Taiyo Kagaku Co., Ltd., Japan has been awarded several manufacturing and use
patents for Suntheanine®, which they have begun to strictly
enforce. The patents cover several applications which include reducing anxiety,
suppressing behavior problems of pets, reducing PMS symptoms, promoting
relaxation, etc.
In addition, several Structure/Function claims have been approved by the
Food and Drug Administration which include:
- Reduces stress
- Promotes relaxation without drowsiness
- Eases nervousness due to common every day overwork and
fatigue
- Reduces nervous irritability
APPLICATIONS:
Currently, Suntheanine® is marketed in capsule form in the
US. It is sold in over 50 different food products in Japan and Korea including
beverages, candy, chocolate, chewing gum and ice cream.
It has been determined that no degradation resulted when beverages
containing Suntheanine® were heated at 121° C for five
minutes. Suntheanine® is also stable in solutions ranging from
3.0 to 6.6 on the pH scale and is 100% soluble in water.
SAFETY:
LD50, a classification of acute ingestion toxicity, determined
Suntheanine® to be greater than 5,000 mg/Kg, causing no
"significant or unreasonable risk of illness or injury".
Suntheanine® has several advantages over other stress
reducing supplements.
Recent reports suggest that Kava Kava may be linked to hepatotoxicity in
such cases as hepatitis, cirrhosis and liver failure.
Valerian has a tendency to promote sleep and drowsiness and may also impair
motor function. In addition, Kava Kava, Valerian and St. John's Wort may have
severe contraindications with alcohol, OTC and prescription drugs.
Suntheanine® is 100% safe with no known drug interactions,
side effects or any limit of duration of administration.
Suntheanine® promotes relaxation safely, without causing
drowsiness or impairing cognitive or motor function.
Suntheanine® was awarded Nutraceutical of the Year at
Nutracon 2000 and the Food Ingredient Research Award at the FIE 1998.
REFERENCES
1. 2000. SuntheanineTM Relaxing, health promoting amino acid
found in tea. Taiyo Kagaku.
2. Juneja L, et al. 1999. L-theanine a unique amino acid of green tea
and its relaxation effect in humans. Trends in Food Science &
Technology. 10: 199-204.
3. Yokozawa T, et al. 1997. Influence of green tea and its three major
components upon low density lipoprotein oxidation. Exp Toxic Pathol 49:
329-335.
4. Yokogoshi H, et al. 1998. Effect of Theanine, r-Glutamylethylamide, on
Brain Monoamines and Striatal Dopamin Release in Conscious Rats.
Neurochemical Research. 23: 667-673.
5. Graham, Harnold N. 1992. Green Tea Composition, Consumption, and
Polyphenol Chemistry. Preventative Medicine. 21: 334-350.
6. Sagesaka Y, et al. Pharmacological Effect of Theanine. Ito-en Central
Research Institute. 362-365.
7. Kobayashi K, et al. 1998. Effects of L-theanine on the Release of a-Brain
Waves in Human Volunteers. Nippon Noegikagaku Kaishi. 72: 153-151.
8. Sugiyama T, Sadzuka Y. Enhancing effects of green tea components on the antitumor activity of adriamycin against
M5076 ovarian carcinoma. Cancer Lett. 1998; 133: 19 26.
|